![Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram](https://www.researchgate.net/profile/Jun-Teishima/publication/263702696/figure/fig2/AS:667619061411855@1536184196912/Overall-survival-curves-for-A-all-140-patients-with-metastatic-renal-cell-carcinoma-and.png)
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
![Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram](https://www.researchgate.net/publication/7781128/figure/fig2/AS:601588360032308@1520441250678/Overall-survival-for-patients-with-progressive-metastatic-renal-cell-carcinoma-treated.png)
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
![Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/04f3cd1a-7ada-455e-84a4-4f0f15bcbde5/gr1_lrg.jpg)
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary
![The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6311-z/MediaObjects/12885_2019_6311_Fig3_HTML.png)
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
![Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study](https://www.frontiersin.org/files/Articles/604724/fonc-11-604724-HTML/image_m/fonc-11-604724-g001.jpg)
Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study
![Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/684b750a-03b5-4494-b310-768504324d01/gr1.jpg)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig2_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5900-1/MediaObjects/12885_2019_5900_Fig3_HTML.png)
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text
![Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419353566-gr1.jpg)
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect
![Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press](https://content.iospress.com/media/kca/2019/3-2/kca-3-2-kca190059/kca-3-kca190059-g003.jpg?width=755)
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
![Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/473816/473816_Thumb_400.jpg)
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
![Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram](https://www.researchgate.net/publication/301480827/figure/fig1/AS:485970496757760@1492875803905/Overall-survival-of-180-patients-with-metastatic-renal-cell-carcinoma-treated-with-IFN-a.png)
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
![Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1e25e3a3-afcb-4c97-a629-b0987a81fd2d/gr1.jpg)
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer
![Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram](https://www.researchgate.net/publication/304249872/figure/fig1/AS:560774998433793@1510710586837/Kaplan-Meier-survival-analyses-of-patients-with-metastatic-renal-cell-carcinoma-treated.png)
Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram
![Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c13539ab-0277-4429-bb72-b18d3730bbca/gr1.jpg)
Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology
![Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/915d787e-fafa-4509-ba32-6b53e5c696de/mfig005.jpg)